BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 10446987)

  • 1. The dermatofibrosarcoma protuberans-associated collagen type Ialpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB.
    Shimizu A; O'Brien KP; Sjöblom T; Pietras K; Buchdunger E; Collins VP; Heldin CH; Dumanski JP; Ostman A
    Cancer Res; 1999 Aug; 59(15):3719-23. PubMed ID: 10446987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis.
    Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH
    Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.
    Greco A; Roccato E; Miranda C; Cleris L; Formelli F; Pierotti MA
    Int J Cancer; 2001 May; 92(3):354-60. PubMed ID: 11291071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).
    Simon MP; Navarro M; Roux D; Pouysségur J
    Oncogene; 2001 May; 20(23):2965-75. PubMed ID: 11420709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans.
    Greco A; Fusetti L; Villa R; Sozzi G; Minoletti F; Mauri P; Pierotti MA
    Oncogene; 1998 Sep; 17(10):1313-9. PubMed ID: 9771975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    Szollosi Z; Scholtz B; Egervari K; Nemes Z
    J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
    Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
    Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
    Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
    Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.
    Simon MP; Pedeutour F; Sirvent N; Grosgeorge J; Minoletti F; Coindre JM; Terrier-Lacombe MJ; Mandahl N; Craver RD; Blin N; Sozzi G; Turc-Carel C; O'Brien KP; Kedra D; Fransson I; Guilbaud C; Dumanski JP
    Nat Genet; 1997 Jan; 15(1):95-8. PubMed ID: 8988177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted treatment for dermatofibrosarcoma protuberans.
    McArthur G
    Semin Oncol; 2004 Apr; 31(2 Suppl 6):30-6. PubMed ID: 15176002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.
    O'Brien KP; Seroussi E; Dal Cin P; Sciot R; Mandahl N; Fletcher JA; Turc-Carel C; Dumanski JP
    Genes Chromosomes Cancer; 1998 Oct; 23(2):187-93. PubMed ID: 9739023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of COL1A1-PDGFB fusion transcripts and platelet-derived growth factor alpha and beta receptors in giant cell fibroblastoma of the postsacrococcygeal region.
    Kashima A; Yamashita A; Moriguchi S; Marutsuka K; Tsumori S; Yoshizato K; Ishihara A; Setoyama M; Asada Y
    Br J Dermatol; 2006 May; 154(5):983-7. PubMed ID: 16634907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content.
    McCarty MF; Somcio RJ; Stoeltzing O; Wey J; Fan F; Liu W; Bucana C; Ellis LM
    J Clin Invest; 2007 Aug; 117(8):2114-22. PubMed ID: 17641778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
    Sirvent N; Maire G; Pedeutour F
    Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
    Rubin BP; Schuetze SM; Eary JF; Norwood TH; Mirza S; Conrad EU; Bruckner JD
    J Clin Oncol; 2002 Sep; 20(17):3586-91. PubMed ID: 12202658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.
    Dadone-Montaudié B; Alberti L; Duc A; Delespaul L; Lesluyes T; Pérot G; Lançon A; Paindavoine S; Di Mauro I; Blay JY; de la Fouchardière A; Chibon F; Karanian M; MacGrogan G; Kubiniek V; Keslair F; Cardot-Leccia N; Michot A; Perrin V; Zekri Y; Coindre JM; Tirode F; Pedeutour F; Ranchère-Vince D; Le Loarer F; Pissaloux D
    Mod Pathol; 2018 Nov; 31(11):1683-1693. PubMed ID: 29955147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.